Market News AIOpen the app

Waters Corporation got FDA approval for its flow cytometry tests that help check for leukemia and lymphoma.

TrialRead the original at prnewswire.com
Good for WAT

Waters received FDA clearance for ready-to-use tests that help assess leukemia and lymphoma. This expands its diagnostic offerings, though the report gives no sales estimate.

WAT · Waters Corporation

AI read · Good for WAT

The AI's read

The new tests give Waters another way to serve labs assessing leukemia and lymphoma. Their ready-to-use format supports complex diagnostic work. The report gives no sales estimate, but the clearance broadens Waters' diagnostic offerings.

Get alerts for WAT

Follow Waters Corporation (WAT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for WAT
Free on the App Store and Google Play, or on the web.